Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Vascular Medicine
Volume 2015 (2015), Article ID 157623, 4 pages
http://dx.doi.org/10.1155/2015/157623
Case Report

Unusual Response of Subclavian In-Stent Restenosis to Balloon Angioplasty in a Patient with HIV

Louisiana State University, 1501 King Highway, Shreveport, LA 71130, USA

Received 23 August 2014; Accepted 25 December 2014

Academic Editor: Antonio Silvestro

Copyright © 2015 Mohammad Atif Rana et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Segev, W. J. Cantor, and B. H. Strauss, “Outcome of percutaneous coronary intervention in HIV-infected patients,” Catheterization and Cardiovascular Interventions, vol. 68, no. 6, pp. 879–881, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. I. Sudano, L. E. Spieker, G. Noll, R. Corti, R. Weber, and T. F. Lüscher, “Cardiovascular disease in HIV infection,” The American Heart Journal, vol. 151, no. 6, pp. 1147–1155, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. P. Y. Hsue, K. Giri, S. Erickson et al., “Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection,” Circulation, vol. 109, no. 3, pp. 316–319, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. G. Dangas, S. Kokolis, R. Mehran et al., “Human immunodeficiency virus infection and high c-reactive protein correlates with increased in-stent restenosis rate,” Journal of the American College of Cardiology, vol. 41, no. 6, supplement 1, 66 pages, 2003. View at Google Scholar
  5. L. E. Spieker, B. Karadag, C. Binggeli, and R. Corti, “Rapid progression of atherosclerotic coronary artery disease in patients with human immunodeficiency virus infection,” Heart and Vessels, vol. 20, no. 4, pp. 171–174, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. K. Kappert, O. Leppänen, J. Paulsson et al., “Highly active antiretroviral therapy attenuates re-endothelialization and alters neointima formation in the rat carotid artery after balloon injury,” Journal of Acquired Immune Deficiency Syndromes, vol. 43, no. 4, pp. 383–392, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. C. A. Sabin, “The changing clinical epidemiology of AIDS in the highly active antiretroviral therapy era,” AIDS, vol. 16, pp. S61–S68, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. K. de Gaetano Donati, R. Rabagliati, M. Tumbarello et al., “Increased soluble markers of endothelial dysfunction in HIV-positive patients under highly active antiretroviral therapy,” AIDS, vol. 17, no. 5, pp. 765–768, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. D.-S. Zhong, X.-H. Lu, B. S. Conklin et al., “HIV protease inhibitor ritonavir induces cytotoxicity of human endothelial cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 10, pp. 1560–1566, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Flinterman, L. Guelen, S. Ezzati-Nik et al., “E1A activates transcription of p73 and noxa to induce apoptosis,” Journal of Biological Chemistry, vol. 280, no. 7, pp. 5945–5959, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus